Jennifer W. Chuy

Oncology

240 E 38th St
New York, NY 10016

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

CLDN18.2-Targeted Therapy in Gastrointestinal Cancers.

CLDN18.2-Targeted Therapy in Gastrointestinal Cancers.

Journal: Cancers

Published: September 17, 2025

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database.

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database.

Journal: The oncologist

Published: August 27, 2024

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma.

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: October 12, 2022

Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban Population.

Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban Population.

Journal: Journal of gastrointestinal cancer

Published: April 27, 2022

The order of surgery and chemotherapy matters: Multimodality therapy and stage-specific differences in survival in gastric cancer.

The order of surgery and chemotherapy matters: Multimodality therapy and stage-specific differences in survival in gastric cancer.

Journal: Journal of surgical oncology

Published: April 06, 2022

Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice.

Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice.

Journal: Science translational medicine

Published: March 23, 2022

The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer.

The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer.

Journal: Journal of gastrointestinal cancer

Published: November 03, 2019

Human papillomavirus, radiation dose and survival of patients with anal cancer.

Human papillomavirus, radiation dose and survival of patients with anal cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 09, 2019

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.

Journal: EClinicalMedicine

Published: May 27, 2019

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin.

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin.

Journal: Oncotarget

Published: April 24, 2019

Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials.

Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials.

Journal: Investigational new drugs

Published: August 14, 2018

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients.

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients.

Journal: Canadian journal of gastroenterology & hepatology

Published: May 21, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026